Following a construction period of just two years, a joint venture between Evonik and the Dutch company DSM has on the 11th July commissioned its globally unique production plant in the US.
Through the fermentative manufacture of natural marine algae, the new plant produces a special algal oil that contains the key omega-3 fatty acids needed for healthy salmon farming.
The two parent companies of the 50:50 joint venture named Veramaris, have invested a total of 200 million US dollars in equal parts for the construction of the plant in Blair, Nebraska. The initial algal oil produced at the plant can sustainably supply approximately 15 percent of the annual demand the global salmon-farming industry has for the two omega-3 fatty acids EPA and DHA. The unique process developed by Evonik and DSM enables the manufacture of EPA and DHA for salmon feed for the first time without using any fish oil from wild-caught fish.
'In Veramaris, we have combined the competencies of two strong partners to make an innovative contribution to the healthy nutrition of the world's growing population, without putting any further burden on our oceans,' says Christian Kullmann, chairman of the Executive Board of Evonik. Feike Sijbesma, CEO/Chairman DSM Managing Board commented, 'I am pleased that together with Evonik we have reached a key milestone in turning the tide: through Veramaris, we are able to reduce the aquaculture industry's reliance on the world's finite fish oil resources for these vital omega-3 fatty acids. This fits perfectly with our purpose-led performance driven strategy, focused on addressing the world's biggest challenges while simultaneously creating economic, environmental and societal value for all our stakeholders.'
Read the full story on the International Aquafeed website, HERE.
Through the fermentative manufacture of natural marine algae, the new plant produces a special algal oil that contains the key omega-3 fatty acids needed for healthy salmon farming.
 |
| The new Veramaris facility for the production of omega-3 EPA & DHA from natural marine algae in Blair, Nebraska Image credit: Evonik |
The two parent companies of the 50:50 joint venture named Veramaris, have invested a total of 200 million US dollars in equal parts for the construction of the plant in Blair, Nebraska. The initial algal oil produced at the plant can sustainably supply approximately 15 percent of the annual demand the global salmon-farming industry has for the two omega-3 fatty acids EPA and DHA. The unique process developed by Evonik and DSM enables the manufacture of EPA and DHA for salmon feed for the first time without using any fish oil from wild-caught fish.
'In Veramaris, we have combined the competencies of two strong partners to make an innovative contribution to the healthy nutrition of the world's growing population, without putting any further burden on our oceans,' says Christian Kullmann, chairman of the Executive Board of Evonik. Feike Sijbesma, CEO/Chairman DSM Managing Board commented, 'I am pleased that together with Evonik we have reached a key milestone in turning the tide: through Veramaris, we are able to reduce the aquaculture industry's reliance on the world's finite fish oil resources for these vital omega-3 fatty acids. This fits perfectly with our purpose-led performance driven strategy, focused on addressing the world's biggest challenges while simultaneously creating economic, environmental and societal value for all our stakeholders.'
Read the full story on the International Aquafeed website, HERE.
The Aquaculturists
This blog is maintained by The Aquaculturists staff and is supported by the
magazine International Aquafeed which is published by Perendale Publishers Ltd
For additional daily news from aquaculture around the world: aquaculture-news
No comments:
Post a Comment